Ctexli significantly reduced levels of two atypical cholesterol metabolites usually elevated in patients with cerebrotendinous xanthomatosis (CTX) compared to the...

Strong positive interim data from an earlier Phase 3 trial has led to early cessation of Merck’s pulmonary arterial hypertension...

In two randomized clinical trials evaluating pain control following abdominoplasty and bunionectomy, Journavx demonstrated statistically significant reductions in acute surgical...

RSV patients treated with antiviral drug S-337395 showed statistically significant reduction in viral load S-337395 is generally safe and well...

Opdivo-Qvantig had a non-inferior objective response rate compared to intravenous formulation in patients with locally advanced or metastatic clear cell...

AURN001 demonstrates improvement of visual acuity in patients with corneal endothelial dysfunction. The CLARA trial demonstrates favorable safety profiles across...

TEV’749 achieved reductions in schizophrenia symptoms, as measured by differences in the Positive and Negative Syndrome Scale (PANSS) scores, from...

Ohtuvayre showed significant improvement in lung function by 12 weeks. Follow-up analyses showed that Ohtuvayre had long-term benefits by reducing...

The addition of Truqap to standard-of-care therapy improved radiographic progression-free survival in patients with metastatic prostate cancer and loss of...

The addition of Monjuvi to standard-of-care therapy reduced the risk of disease progression, relapse, or death in patients with relapsed/refractory...